EU agrees potential 1.8 billion-dose purchase of Pfizer jab
[unable to retrieve full-text content]
The European Union has cemented its support for Pfizer-BioNTech and its novel COVID-19 vaccine technology by agreeing to a massive contract extension for a potential 1.8 billion doses through 2023
